Skip to main content
. 2015 Jun 16;100(9):3443–3451. doi: 10.1210/jc.2015-2022

Table 1.

Demographic, PHPT, and Lifestyle Characteristics by Vitamin D Status

25OHD, ng/mL
P Value
<20 20–29 ≥30
n 19 35 46
Age, y 56.6 ± 2.7 58.5 ± 2.0 66.8 ± 1.7a,b .0009
Females, n/% 14/17.7 25/31.7 40/50.6 .19
Postmenopausal women, n/% 10/71.4 20/80.0 40/100 <.01
Age at menopause, y 47.6 ± 2.2 49.0 ± 1.5 50.9 ± 1.1 .33
Height, cm 166.4 ± 2.0 165.9 ± 1.5 162.6 ± 1.3 .17
Weight, kg 83.3 ± 4.4 79.2 ± 3.2 71.1 ± 2.8c .04
BMI, kg/m2 29.5 ± 1.4 28.7 ± 1.0 26.8 ± 0.9 .16
White, n/% 14/87.5 30/85.7 42/93.3 .58
Hispanic, n/% 5/26.3 5/14.3 7/15.2 .48
PHPT duration, y 3.0 ± 1.4 3.6 ± 1.0 5.2 ± 0.9 .30
Meets surgical guidelines, n/% 16/84.2 20/57.1 33/71.7 .10
Calcium intake, mg/d 867 ± 185 1033 ± 139 1197 ± 119 .31
Taking vitamin D supplements, n/% 5/26.3 21/60.0 39/84.8 <.0001
Daily supplement use, IU/d 711 ± 631 1056 ± 308 2059 ± 226c,d .01
Current tobacco use, n/% 1/5.3 1/2.9 4/8.7 .83
Sun exposure score 8.3 ± 1.4 8.5 ± 1.0 9.1 ± 0.9 .84

Data are expressed as means ± SEM, unless stated otherwise.

a

P < .01 compared to 25OHD <20 ng/mL.

b

P < .01 compared to 25OHD 20–29 ng/mL.

c

P < .05 compared to 25OHD <20 ng/mL.

d

P < .05 compared to 25OHD 20–29 ng/mL.